Illumina, Inc. ILMN NASDAQ

Illumina, Inc. (ILMN) reported total assets of $6.64B and total liabilities of $3.92B for fiscal year 2025, resulting in total equity of $2.72B.

The company held $1.63B in cash and short-term investments. Total debt stood at $2.55B, with net debt of $1.14B. The Debt-to-Equity (D/E) ratio was 0.94 (moderate).

Current ratio is 2.08, indicating strong short-term liquidity. Interest coverage is 8.7x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.94, current ratio of 2.08, interest coverage 8.7x — balance sheet is strong
• MOAT (76/100) — Total assets $6.64B and equity $2.72B support the company's competitive scale
• VALUE (66/100) — Debt-to-Equity 0.94 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 61/100 with 4/7 criteria passed.

TMO

Thermo Fisher Scientific Inc.

$527.22

+2.53%

DHR

Danaher Corporation

$198.61

+1.40%

IDXX

IDEXX Laboratories, Inc.

$584.05

+1.75%

A

Agilent Technologies, Inc.

$120.40

+2.47%

NTRA

Natera, Inc.

$214.64

+6.31%

EXAS

Exact Sciences Corporation

$104.91

+0.00%

WAT

Waters Corporation

$330.98

+1.94%

TWST

Twist Bioscience Corporation

$57.41

+13.95%